GovGazette
Menu

Historical award

Kaleo, Inc.

This record is historical buying context, not open work.

How current is this award history?

Fiscal year 2025: data through (14 days old).

Fiscal year 2026: data through (14 days old).

Official release availability details

Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Current award value
$96,058,494.00
Potential award value
$340,910,795.00
Total obligated to date
$96,058,494.00

Recorded work

THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION PRODUCT) TO TREAT ORGANOPHOSPHATE (OP) POISONING, INCLUDING NERVE AGENT

Award activity

Obligations in covered fiscal years
$96,058,494.00
Transactions in covered fiscal years
1

Award value and obligated funds describe different amounts. Review the official record for the full transaction history.

Record identifierCONT_AWD_75A50126C00010_7505_-NONE-_-NONE-